Study Title: A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer: Big Ten Cancer Research Consortium. BTCRC-LUN17-127
 

• Status: Completed

• Participating Sites:
  • University of Illinois Cancer Center
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center
  • Masonic Cancer Center, University of Minnesota
  • Rutgers Cancer Institute of New Jersey
  • City of Hope
  • Henry Ford Health System
  • Moffitt Cancer Center
• Learn more:
  • clinicaltrials.gov: NCT03575793
  • Big Ten CRC News Release
• Publications and Presentations:
  • Poster Presentation: 2023 Society for Immunotherapy of Cancer
  • Poster Session: 2021 ASCO Annual Meeting